AlloVir, Inc. (ALVR)

NASDAQ: ALVR · Real-Time Price · USD

0.404

-0.046 (-10.22%)

At close: Dec 20, 2024, 4:00 PM

0.419

+0.015 (3.71%)

After-hours: Dec 20, 2024, 6:51 PM EST

AlloVir Employees

AlloVir had 112 employees as of December 31, 2023. The number of employees increased by 6 or 5.66% compared to the previous year.

Employees

112

Change (1Y)

6

Growth (1Y)

5.66%

Revenue / Employee

n/a

Profits / Employee

-$894,616

Market Cap

46.24M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2023	112	6	5.66%
Dec 31, 2022	106	-1	-0.93%
Dec 31, 2021	107	54	101.89%
Dec 31, 2020	53	-	-

Related Stocks

Company Name	Employees
LakeShore Biopharma	758
SHL Telemedicine	583
Singular Genomics Systems	255
Mural Oncology	117
VolitionRx	110
Invivyd	95
IO Biotech	68
Reviva Pharmaceuticals Holdings	15

Employee Rankings

ALVR News

6 weeks ago - ALLOVIR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AlloVir, Inc. - ALVR - Business Wire
6 weeks ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EMKR and ALVR on Behalf of Shareholders - GlobeNewsWire
6 weeks ago - AlloVir and Kalaris Therapeutics Announce Agreement for Transformational Merger to Create Company Focused on Diseases of the Retina - GlobeNewsWire
3 months ago - Kuehn Law Encourages Investors of AlloVir, Inc. to Contact Law Firm - GlobeNewsWire
9 months ago - FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm - Accesswire
9 months ago - FINAL DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm - Accesswire
10 months ago - MARCH 19 FINAL DEADLINE: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm - Accesswire
10 months ago - INVESTOR DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm - Accesswire